Phase 1b safety study of farletuzumab, carboplatin and pegylated liposomal doxorubicin in patients with platinum-sensitive epithelial ovarian cancer (Q36508941)
Jump to navigation
Jump to search
scientific article published on 28 November 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 1b safety study of farletuzumab, carboplatin and pegylated liposomal doxorubicin in patients with platinum-sensitive epithelial ovarian cancer |
scientific article published on 28 November 2015 |
Statements
1 reference
Phase 1b safety study of farletuzumab, carboplatin and pegylated liposomal doxorubicin in patients with platinum-sensitive epithelial ovarian cancer (English)
1 reference
Kenneth H Kim
1 reference
Danijela Jelovac
1 reference
Deborah K Armstrong
1 reference
Benjamin Schwartz
1 reference
Susan C Weil
1 reference
Charles Schweizer
1 reference
Ronald D Alvarez
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference